יHadassah Ein Karem Medical Center

Jerusalem 9112001

1 studies enrolling now · 7 studies all time

What they study most

Acromegaly, Acute Myocardial Infarction, Brain Infarction, Cerebral Ischemia, Diverticulitis, Follicular Lymphoma, Incomplete HCT (Hematopoietic Cell Transplantation), Metastatic Breast Cancer, Non-Hodgkin Lymphoma, Percutaneous Coronary Revascularization, STEMI, Stroke

Studies at this site

• Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation — Recruiting now
• Evaluation in STEMI Patients Using FDY-5301 — Completed
• A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma — Completed
• Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation — Completed
• Prevention of Recurrence of Diverticulitis — Completed
• Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly — Status unconfirmed
• ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke — Stopped early